{% extends "layout.html" %}
  
{% block title %}Parts{% endblock %}
{% block lead %}This page contains information about the parts created by the team.{% endblock %}

{% block extraStyles %}

<link href="{{ url_for('static', filename = 'css/parts.css') }}" rel="stylesheet">

{% endblock %}

{% block page_content %}
<div class="standard-header banner-v2 curvy-divider">
  <h1> Parts </h1>
  <div class="simple-wave-divider">
    <svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1200 120" preserveAspectRatio="none">
        <path d="M985.66,92.83C906.67,72,823.78,31,743.84,14.19c-82.26-17.34-168.06-16.33-250.45.39-57.84,11.73-114,31.07-172,41.86A600.21,600.21,0,0,1,0,27.35V120H1200V95.8C1132.19,118.92,1055.71,111.31,985.66,92.83Z" class="shape-fill"></path>
    </svg>
  </div>
</div>

<div class="d-flex flex-column align-items-center justify-content-center curvy-divider">
  <div class="body-container wave-div narrow">
    <div class="narrow-content d-flex flex-row align-items-center justify-content-center flex-wrap flex-lg-nowrap">
      <div class="container">
        <h2>Parts Catalog</h2>
        <p>All of the parts created and documented over the course of the project are on this page. Below is a table of parts added to the registry, along with a plasmid viewer to help visualize all of our parts. All parts seen here have been engineered by the Virginia iGEM Team using components of publicly-available antibody sequences.</p>
      </div>
      <div class="img-wrapper plasmid-viewer">
        <img src="https://static.igem.wiki/teams/4477/wiki/images/plasmidwindow.svg" alt="plasmid window">
      </div>
    </div>
  </div>

  <div class="gray-divider">
    <svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1200 120" preserveAspectRatio="none">
      <path d="M985.66,92.83C906.67,72,823.78,31,743.84,14.19c-82.26-17.34-168.06-16.33-250.45.39-57.84,11.73-114,31.07-172,41.86A600.21,600.21,0,0,1,0,27.35V120H1200V95.8C1132.19,118.92,1055.71,111.31,985.66,92.83Z" class="shape-fill"></path>
    </svg>
  </div>
</div>



  <div class="gray d-flex flex-column align-items-center justify-content-center">
    <div class="body-container">
      <div class="body-section top-page">
        <div class="text-wrapper">
          <h2>Parts Table</h2>
          <p>We added a total of ten basic parts (BBa_K4477001-BBa_K4477010) and four composite parts (BBa_K4477011-BBa_K4477014) to the registry. </p>
        </div>
      </div> 
        
      <div class="body-section">
        <div class="text-wrapper">
          <h4>Basic Parts</h4>
        </div>
        <div class="tbl-wrapper">
          <table class="table table-striped">
            <thead>
              <tr>
                <th scope="col">Part Number</th>
                <th scope="col">Type</th>
                <th scope="col">Description</th>
                <th scope="col">Designers</th>
                <th scope="col">Length</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477001">BBa_K4477001</a></th>
                <td>Coding, Anti-oxLDL IgG Light Chain</td>
                <td>This sequence codes for the light chain of an anti-apoB(MDA) immunoglobulin G (IgG), an Orticumab-biosimilar antibody</td>
                <td>Miranda Khoury</td>
                <td>654 bp</td>
              </tr>
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477002">BBa_K4477002</a></th>
                <td>Coding, Anti-oxLDL IgG Heavy Chain</td>
                <td>This sequence codes for the heavy chain of an anti-apoB(MDA) immunoglobulin G (IgG), an Orticumab-biosimilar antibody</td>
                <td>Miranda Khoury</td>
                <td>1338 bp</td>
              </tr>
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477003">BBa_K4477003</a></th>
                <td>Coding, IK17 Anti-oxLDL scFv Antibody</td>
                <td>This sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL IK17 antibody. Specifically, this scFv targets a protein structure called MDA-modified apo-B (apoB(MDA)) that is part of an oxLDL molecule.</td>
                <td>Miranda Khoury</td>
                <td>795 bp</td>
              </tr>
    
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477004">BBa_K4477004</a></th>
                <td>Coding, McPC603 Anti-oxLDL scFv Antibody</td>
                <td>This sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL McPC603 antibody, which targets oxidized phosphocholine on oxLDL.</td>
                <td>Miranda Khoury</td>
                <td>798 bp</td>
              </tr>
    
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477005">BBa_K4477005</a></th>
                <td>Coding, Anti-mouse Camelid VHH Antibody</td>
                <td>This sequence codes for a VHH region antibody fragment, also referred to as an nanobody. It binds to the constant chain region of mouse-derived IgGs.</td>
                <td>Miranda Khoury</td>
                <td>408 bp</td>
              </tr>
    
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477006">BBa_K4477006</a></th>
                <td>RBS, Orticumab-Biosimilar Light Chain expression</td>
                <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of an IgG light chain for an anti-oxLDL antibody we designed (BBa_K4477001).</td>
                <td>Miranda Khoury</td>
                <td>27 bp</td>
              </tr>
    
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477007">BBa_K4477007</a></th>
                <td>RBS, Orticumab-Biosimilar Heavy Chain expression</td>
                <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of the heavy chain of our Orticumab biosimilar (anti-oxLDL) antibody (BBa_K4477002).</td>
                <td>Miranda Khoury</td>
                <td>26 bp</td>
              </tr>
    
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477008">BBa_K4477008</a></th>
                <td>RBS, IK17 scFv expression </td>
                <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed IgG heavy chains (BBa_K4477003).</td>
                <td>Miranda Khoury</td>
                <td>30 bp</td>
              </tr>
    
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477009">BBa_K4477009</a9</th>
                <td>RBS, McPC603 scFv expression</td>
                <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed scFvs (BBa_K4477004).</td>
                <td>Miranda Khoury</td>
                <td>31 bp</td>
              </tr>
    
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477010">BBa_K4477010</a></th>
                <td>RBS, VHH expression</td>
                <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed VHH antibody fragments (BBa_K4477005).</td>
                <td>Miranda Khoury</td>
                <td>39 bp</td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
        
  
      <div class="body-section bottom-page">
        <div class="text-wrapper">
          <h4>Composite Parts</h4>
        </div>
        <div class="tbl-wrapper">
          <table class="table table-striped">
            <thead>
              <tr>
                <th scope="col">Part Number</th>
                <th scope="col">Type</th>
                <th scope="col">Description</th>
                <th scope="col">Designers</th>
                <th scope="col">Length</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477011">BBa_K4477011</a></th>
                <td>Composite, Orticumab-biosimilar Anti-human oxLDL Complete Expression Cassette</td>
                <td>This sequence codes for a full IgG anti-apoB(MDA). It is derived partially from Orticumab, a human antibody that is currently in development.</td>
                <td>Miranda Khoury</td>
                <td>2186 bp</td>
              </tr>
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477012">BBa_K4477012</a></th>
                <td>Composite, IK17 scFv Anti-oxLDL Complete Expression Cassette </td>
                <td>TThis sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL IK17 antibody, which binds to MDA-modified apolipoprotein B on oxLDL.</td>
                <td>Miranda Khoury</td>
                <td>988 bp</td>
              </tr>
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477013">BBa_K4477013</a></th>
                <td>Composite, McPC603 scFv Anti-oxLDL Complete Expression Cassette</td>
                <td>This sequence codes for a short chain variable fragment (scFv) derived from the anti-phosphocholine McPC603 antibody, which binds to oxidized phosphocholine on oxLDL.</td>
                <td>Miranda Khoury</td>
                <td>992 bp</td>
              </tr>
    
              <tr>
                <th scope="row"><a target="_blank" rel="noopener noreferrer" href="http://parts.igem.org/Part:BBa_K4477014">BBa_K4477014</a></th>
                <td>Composite, Anti-mouse Camelid VHH Antibody Complete Expression Cassete</td>
                <td>This sequence codes for a heavy chain variable fragment (VHH), also known as a nanobody, that binds to the Fc region of murine IgGs. </td>
                <td>Miranda Khoury</td>
                <td>610 bp</td>
              </tr>
            </tbody>
          </table>
  
        </div>
      </div>
        
  
    </div>
  </div>
  
  <!-- <div class="container">
    <div class="body-section">
      <div class="container d-flex flex-column">
        <h4>Antibody 1 [Orticumab Biosimilar] Complete Device (4892 bp)</h4>

        <div class="hidden" id="root">
          <script src="{{ url_for('static', filename='seqviz/seqviz.min.js') }}"></script>
    
          <script>
              var viewer = seqviz.Viewer("root", {
              name: "Antibody 1 Plasmid",
              seq: "TAAGGATGATTTCTGGAATTCGCGGCCGCTTCTAGAGCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACATACTAGAGAAAGAGGAGAAATACTAGATGGCTTCCTCCGAAGACGTTATCAAAGAGTTCATGCGTTTCAAAGTTCGTATGGAAGGTTCCGTTAACGGTCACGAGTTCGAAATCGAAGGTGAAGGTGAAGGTCGTCCGTACGAAGGTACCCAGACCGCTAAACTGAAAGTTACCAAAGGTGGTCCGCTGCCGTTCGCTTGGGACATCCTGTCCCCGCAGTTCCAGTACGGTTCCAAAGCTTACGTTAAACACCCGGCTGACATCCCGGACTACCTGAAACTGTCCTTCCCGGAAGGTTTCAAATGGGAACGTGTTATGAACTTCGAAGACGGTGGTGTTGTTACCGTTACCCAGGACTCCTCCCTGCAAGACGGTGAGTTCATCTACAAAGTTAAACTGCGTGGTACCAACTTCCCGTCCGACGGTCCGGTTATGCAGAAAAAAACCATGGGTTGGGAAGCTTCCACCGAACGTATGTACCCGGAAGACGGTGCTCTGAAAGGTGAAATCAAAATGCGTCTGAAACTGAAAGACGGTGGTCACTACGACGCTGAAGTTAAAACCACCTACATGGCTAAAAAACCGGTTCAGCTGCCGGGTGCTTACAAAACCGACATCAAACTGGACATCACCTCCCACAACGAAGACTACACCATCGTTGAACAGTACGAACGTGCTGAAGGTCGTCACTCCACCGGTGCTTAATAACGCTGATAGTGCTAGTGTAGATCGCTACTAGAGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATACTAGTAGCGGCCGCTGCAGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATCTCGAGTCCCGTCAAGTCAGCGTAATGCTCTGCCAGTGTTACAACCAATTAACCAATTCTGATTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCGATACCATATTTTTGAAAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGCTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTGGAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGATGATATATTTTTATCTTGTGCAATGTAACATCAGAGATTTTGAGACACAACGTGGCTTTGTTGAATAAATCGAACTTTTGCTGAGTTGAAGGATCAGATCACGCATCTTCCCGACAACGCAGACCGTTCCGTGGCAAAGCAAAAGTTCAAAATCACCAACTGGTCCACCTACAACAAAGCTCTCATCAACCGTGGCTCCCTCACTTTCTGGCTGGATGATGGGGCGATTCAGGCCTGGTATGAGTCAGCAACACCTTCTTCACGAGGCAGACCTCAGCGCTAGCGGAGTGTATACTGGCTTACTATGTTGGCACTGATGAGGGTGTCAGTGAAGTGCTTCATGTGGCAGGAGAAAAAAGGCTGCACCGGTGCGTCAGCAGAATATGTGATACAGGATATATTCCGCTTCCTCGCTCACTGACTCGCTACGCTCGGTCGTTCGACTGCGGCGAGCGGAAATGGCTTACGAACGGGGCGGAGATTTCCTGGAAGATGCCAGGAAGATACTTAACAGGGAAGTGAGAGGGCCGCGGCAAAGCCGTTTTTCCATAGGCTCCGCCCCCTGACAAGCATCACGAAATCTGACGCTCAAATCAGTGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGCGGCTCCCTCGTGCGCTCTCCTGTTCCTGCCTTTCGGTTTACCGGTGTCATTCCGCTGTTATGGCCGCGTTTGTCTCATTCCACGCCTGACACTCAGTTCCGGGTAGGCAGTTCGCTCCAAGCTGGACTGTATGCACGAACCCCCCGTTCAGTCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGAAAGACATGCAAAAGCACCACTGGCAGCAGCCACTGGTAATTGATTTAGAGGAGTTAGTCTTGAAGTCATGCGCCGGTTAAGGCTAAACTGAAAGGACAAGTTTTGGTGACTGCGCTCCTCCAAGCCAGTTACCTCGGTTCAAAGAGTTGGTAGCTCAGAGAACCTTCAAAAAACCGCCCTGCAAGGCGGTTTTTTCGTTTTCAGAGCAAGAGATTACGCGCAGACCAAAACGATCTCAAGAAGATCATCTTATTAAGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTCCATGGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCAGAATTTCAGATAAAAAAAATCCTTAGCTTTCGC",
              style: { height: "80vh", width: "80vw" },
  
              annotations:
                  [{ start: 311, end: 988, name: "mRFP1", color: "red", direction: 1 }, // [0, 22)
              ],
              })
              viewer.render();
              viewer.renderToString();
  
          </script>
        </div>
      </div>
    </div>
  </div> -->


{% endblock %}
